title: Development of comprehensive functional genomic screens to identify novel mediators of osteoarthritis.
abstract: OBJECTIVE
  The aim of this study was to develop high-throughput assays for the analysis of major chondrocyte functions that are important in osteoarthritis (OA) pathogenesis and methods for high-level gene expression and analysis in primary human chondrocytes.
  
  
  METHODS
  In the first approach, complementary DNA (cDNA) libraries were constructed from OA cartilage RNA and full-length clones were selected. These cDNAs were transferred into a retroviral vector using Gateway Technology. Full-length clones were over-expressed in human articular chondrocytes (HAC) by retroviral-mediated gene transfer. The induction of OA-associated markers, including aggrecanase-1 (Agg-1), matrix metalloproteinase-13 (MMP-13), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), collagen IIA and collagen X was measured by quantitative real-time polymerase chain reaction (QPCR). Induction of a marker gene was verified by independent isolation of 2-3 clones per gene, re-transfection followed by QPCR as well as nucleotide sequencing. In the second approach, whole cDNA libraries were transduced into chondrocytes and screened for chondrocyte cluster formation in three-dimensional agarose cultures.
  
  
  RESULTS
  Using green fluorescent protein (eGFP) as a marker gene, it was shown that the retroviral method has a transduction efficiency of >90%. A total of 40 verified hits were identified in the QPCR screen. The first set of 19 hits coordinately induced iNOS, COX-2, Agg-1 and MMP-13. The most potent of these genes were the tyrosine kinases Axl and Tyro-3, receptor interacting kinase-2 (RIPK2), tumor necrosis factor receptor 1A (TNFR1A), fibroblast growth factor (FGF) and its receptor FGFR, MUS81 endonuclease and Sentrin/SUMO-specific protease 3. The second set of seven hits induced both Agg-1 and MMP-13 but none of the other markers. Five of these seven genes regulate the phosphoinositide-3-kinase pathway. The most potently induced OA marker was iNOS. This marker was induced 20-500 fold by seven genes. Collagen IIA was also induced by seven genes, the most potent being transforming growth factor beta (TGFbeta)-stimulated protein TSC22, vascular endothelial growth factor (VEGF) and splicing factor 3a. This screening assay did not identify inducers of collagen X. The second chondrocyte cluster formation screen identified 14 verified hits. Most of the genes inducing cluster formation were kinases. Additional genes had not been previously known to regulate chondrocyte cluster formation or any other chondrocyte function.
  
  
  CONCLUSIONS
  The methods developed in this study can be applied to screen for genes capable of inducing an OA-like phenotype in chondrocytes on a genome-wide scale and identify novel mediators of OA pathogenesis. Thus, coordinated functional genomic approaches can be used to delineate key genes and pathways activated in complex human diseases such as OA.
authors.affiliation: Department of Functional Genomics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
authors.forename: S
authors.initials: S
authors.lastname: Daouti
authors.forename: B
authors.initials: B
authors.lastname: Latario
authors.forename: S
authors.initials: S
authors.lastname: Nagulapalli
authors.forename: F
authors.initials: F
authors.lastname: Buxton
authors.forename: S
authors.initials: S
authors.lastname: Uziel-Fusi
authors.forename: G-W
authors.initials: GW
authors.lastname: Chirn
authors.forename: D
authors.initials: D
authors.lastname: Bodian
authors.forename: C
authors.initials: C
authors.lastname: Song
authors.forename: M
authors.initials: M
authors.lastname: Labow
authors.forename: M
authors.initials: M
authors.lastname: Lotz
authors.forename: J
authors.initials: J
authors.lastname: Quintavalla
authors.forename: C
authors.initials: C
authors.lastname: Kumar
mesh_terms: D002358:Cartilage, Articular / Q000378:metabolism*; D019902:Chondrocytes / Q000378:metabolism*; D015723:Gene Library; D005819:Genetic Markers; D005820:Genetic Testing / Q000379:methods*; D049452:Green Fluorescent Proteins; D006801:Humans; D007150:Immunohistochemistry; D010003:Osteoarthritis / Q000235:genetics*; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012190:Retroviridae; D014161:Transduction, Genetic
chemical_list: D005819:Genetic Markers; D049452:Green Fluorescent Proteins